Book an AppointmentPlease book an appointment as early as possible within your destination’s allowed timeframe.
You can visit StageZeroBORDERPASS.com to determine the ideal time for your test. Appointments can be scheduled Mon-Sat in Canada and the US. All appointments are in Eastern Time. |
Call 1-800-Go-Fedex on the day before your appointment to schedule an express pick-up for directly after your appointment.
Questions? Contact us at 804-261-3340 or support@stagezerols.com if you have any questions.
|
Additional Instructions
Do not drink any fluids, smoke, chew gum, brush your teeth or eat for 30 minutes prior to your appointment, or your test sample will be considered invalid. Please FEDEX your test sample to the STAGEZERO lab immediately after your appointment. • Make a note of your tracking number so that you can monitor your shipment
Please set aside at least 15 minutes for your appointment and have your identification on hand. Before your appointment, please test your device to ensure the sound and video are working properly.
You will receive an email reminder 30 minutes prior to your appointment with a link. Click the “Begin Your Online Appointment” link to join.
Your coach will verify your identity and walk you through the sample collection and packaging process
Please FEDEX your test sample to the STAGEZERO lab immediately after your appointment. • Make a note of your tracking number so that you can monitor your shipment.
|
Keep your box. Do not damage or discard the box containing your supplies. You will need your box to return your sample to the STAGEZERO lab for processing.
Please keep the saliva tube in the sealed pouch until your appointment. Do not attempt to collect the saliva sample without the online video supervision of a healthcare professional. |
Your Results
|
StageZero Life Sciences is not responsible for delayed test results due to shipping, weather or errors made in your registration process (i.e. users providing an incorrect email address). Should any of these risks materialize, a refund will not be issued.
For Travelers: We are also NOT responsible for determining the timing required for your test. Please check with your airlines and destinations to determine your testing date and the types of tests needed. |
The TaqPath™ RT-PCR COVID-19
Disclaimer:
This test has been authorized by FDA under an EUA for use by authorized laboratories and by Health Canada under Interim Order No. 2 for importing and selling medical devices; This test has been authorized only for the detection of nucleic acid from SARSCoV-2, not for any other viruses or pathogens; This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. This test has not been FDA cleared or approved. This test is for Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.
This test is performed by StageZero in our CLIA-certified high complexity laboratory, using a PCR-based test kit that has been granted emergency use authorization by FDA for detection of SARS-CoV-2 in nasopharyngeal swab, nasopharyngeal aspirate, and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. StageZero has internally validated test kit performance for detection of SARS-CoV-2 in saliva. In a study(1) of 50 patients with known COVID-19 status, across 3 hospitals, using the Spectrum SDNA-1000 saliva collection device in conjunction with the ThermoFisher TaqPath COVID-19 Combo Kit, the following results were achieved for saliva:
This test has been authorized by FDA under an EUA for use by authorized laboratories and by Health Canada under Interim Order No. 2 for importing and selling medical devices; This test has been authorized only for the detection of nucleic acid from SARSCoV-2, not for any other viruses or pathogens; This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. This test has not been FDA cleared or approved. This test is for Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.
This test is performed by StageZero in our CLIA-certified high complexity laboratory, using a PCR-based test kit that has been granted emergency use authorization by FDA for detection of SARS-CoV-2 in nasopharyngeal swab, nasopharyngeal aspirate, and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. StageZero has internally validated test kit performance for detection of SARS-CoV-2 in saliva. In a study(1) of 50 patients with known COVID-19 status, across 3 hospitals, using the Spectrum SDNA-1000 saliva collection device in conjunction with the ThermoFisher TaqPath COVID-19 Combo Kit, the following results were achieved for saliva:
- 100% Positive and Negative agreement for contrived samples
- 100% Positive agreement for 1-2x Limit of Detection (LoD)
- 100% Agreement on all clinical samples
- 100% Agreement on swab vs. saliva results in clinical samples